Skip to main content

Trill AB's Form 4 filing

DiaMedica Therapeutics Inc. (DMAC) · filed Sep 4, 2025

Accession no.
0001104659-25-087410
Filed
Sep 4, 2025, 2:29 PM ET
Trade date
Aug 13-27, 2025
Filing delay
22 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.96M. It was filed 22 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Trill ABCIK 000188743610% Owner
Stahlberg JanCIK 000198316110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 13, 2025Common SharesPPurchaseAcquired+293,601$5.91+$1,734,917.677,058,066Indirect
Aug 14, 2025Common SharesPPurchaseAcquired+70,414$5.99+$421,920.697,128,480Indirect
Aug 15, 2025Common SharesPPurchaseAcquired+8,233$6.00+$49,3987,136,713Indirect
Aug 20, 2025Common SharesPPurchaseAcquired+71,107$5.86+$416,495.037,207,820Indirect
Aug 21, 2025Common SharesPPurchaseAcquired+48,172$5.96+$287,028.047,255,992Indirect
Aug 22, 2025Common SharesPPurchaseAcquired+59,788$5.96+$356,575.637,315,780Indirect
Aug 25, 2025Common SharesPPurchaseAcquired+338,265$6.00+$2,029,251.747,654,045Indirect
Aug 26, 2025Common SharesPPurchaseAcquired+59,648$6.00+$357,8887,713,693Indirect
Aug 27, 2025Common SharesPPurchaseAcquired+50,772$6.00+$304,6327,764,465Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)